É³ÌØ°¢À­²®°¬²·¹þµØÇøÒ½Ê¦Ñ­Ö¤Ò½Ñ§Ì¬¶ÈÓë×Ô±¨Ó¦ÓÃˮƽ£ºÒ»Ïîºá¶ÏÃæÑо¿

¡¶Healthcare¡·£ºAttitudes and Self-Reported Use of Evidence-Based Medicine Among Physicians in Abha, Saudi Arabia: A Cross-Sectional Study Lama Ali Buhran, Syed Esam Mahmood, Wejdan Fuad Abbag, Abdulrahman Ali Buhran and Razia Aftab Ahmed

¡¾×ÖÌ壺 ´ó ÖРС ¡¿ ʱ¼ä£º2026Äê03ÔÂ21ÈÕ À´Ô´£ºHealthcare 2.7

±à¼­ÍƼö£º

¡¡¡¡±¾Ñо¿Ö¼ÔÚµ÷²éÉ³ÌØ°¢À­²®°¬²·¹þµØÇøÖ´ÒµÒ½Ê¦µÄѭ֤ҽѧ£¨EBM£©Ó¦ÓÃÏÖ×´£¬Ê¶±ðÖ÷ÒªÕϰ­£¬²¢±È½Ï²»Í¬Ò½ÔºÀàÐͼäµÄ²îÒ졣ͨ¹ý¶Ô273ÃûҽʦµÄµ÷²é·¢ÏÖ£¬¾¡¹Üҽʦ¶ÔEBM³Ö»ý¼«Ì¬¶È£¬µ«Êµ¼ÊÁÙ´²Ó¦ÓÃÖÐEBMÕ¼±ÈÖÐλÊý½öΪ50%£¬ÇÒ¶ÔרҵÊý¾Ý¿âµÄÀûÓÃÓÐÏÞ£¬Ê±¼ä²»×ãºÍÑо¿ÊÊÓÃÐÔµ£ÓÇÊÇÖ÷ÒªÕϰ­¡£¸ÃÑо¿½ÒʾÁË¡°Ì¬¶È-ʵ¼ù¡±²îÒ죬ΪÕë¶ÔÐÔ¸ÉÔ¤ÌṩÁËÒÀ¾Ý¡£

¡¡¡¡
ÔÚÏÖ´úҽѧʵ¼ùÖУ¬Ñ­Ö¤Ò½Ñ§£¨EBM£¬ Evidence-Based Medicine£©±»ÓþΪÌá¸ßÒ½ÁÆÖÊÁ¿ºÍ¾ö²ß¿ÆÑ§ÐԵĻùʯ¡£ËüÖ÷ÕÅÁÙ´²¾ö²ßÓ¦»ùÓÚµ±Ç°×î¼ÑµÄ¿ÆÑ§Ö¤¾Ý£¬½áºÏÁÙ´²Ò½ÉúµÄרҵ¼¼Äܺͻ¼ÕߵļÛÖµÓëÆ«ºÃ£¬´Ó¶ø´øÀ´¸üºÃµÄ»¼Õß½á¾Ö¡¢¼õÉÙʵ¼ù²îÒì²¢´Ù½øÒ½Áư²È«¡£È»¶ø£¬ÀíÏë·áÂú£¬ÏÖʵ¹Ç¸Ð¡£¾¡¹ÜÆäÖØÒªÐÔ±»¹ã·ºÈϿɣ¬È«Çò¸÷µØµÄҽʦÃÇÔÚ½«EBMÔ­ÔòÈÚÈëÈÕ³£ÕïÁÆÊ±£¬ÒÀÈ»ÃæÁÙ×ÅÖØÖØ×è°­¡£ÔÚÉ³ÌØ°¢À­²®£¬Çé¿öÒ²²»ÀýÍ⣬ÏÖÓÐÑо¿½ÒʾÁËҽʦ¶ÔEBMµÄÈÏÖª¡¢Ì¬¶ÈÓëʵ¼ÊÓ¦ÓÃÖ®¼ä´æÔÚÁîÈ˵£ÓǵIJî¾à¡£
ΪÁËÌî²¹É³ÌØ°¬¹þÈøµØÇøÑ­Ö¤Ò½Ñ§ÊµÊ©Çé¿öµÄÊý¾Ý¿Õ°×£¬Lama Ali Buhran, Syed Esam Mahmood, Wejdan Fuad Abbag, Abdulrahman Ali Buhran ºÍ Razia Aftab Ahmed µÈÑо¿ÈËÔ±ÔÚ¡¶Healthcare¡·ÆÚ¿¯ÉÏ·¢±íÁËÒ»ÏîÑо¿¡£ËûÃÇÏëÖªµÀ£º°¬²·¹þµÄҽʦÃǾ¿¾¹ÔÚ¶à´ó³Ì¶ÈÉÏÓ¦ÓÃEBM£¿ÊÇÄÄЩÒòËØÔÚÍϺóÍÈ£¿´ËÍ⣬ÔÚÕþ¸®½ÌѧҽԺºÍ˽Á¢Ò½Ôº¹¤×÷µÄҽʦ£¬ÆäEBMÓ¦ÓÃˮƽÊÇ·ñÓвîÒ죿ÕâЩÎÊÌâµÄ´ð°¸£¬¶ÔÓÚÖÆ¶¨ÓÐЧµÄ²ßÂÔ¡¢Íƶ¯Ö¤¾ÝÔÚÁÙ´²ÖеÄÇÐʵӦÓÃÖÁ¹ØÖØÒª¡£
ΪÁ˽â´ðÉÏÊöÎÊÌ⣬Ñо¿ÍŶӲÉÓÃÁËÒ»ÖֹؼüµÄ¼¼Êõ·½·¨£ºÒ»Ïî·ÖÎöÐÔºá¶ÏÃæµ÷²é¡£Ñо¿ÓÚ2024Äê12ÔÂÖÁ2025Äê9ÔÂÆÚ¼ä£¬Í¨¹ý¾­ÊÚȨ¸Ä±àµÄ¡¢¿É¿¿¶È½Ï¸ß£¨Cronbach's alpha 0.87£©µÄ27Ïî½á¹¹»¯µç×ÓÎÊ¾í£¬¶ÔÀ´×Ô°¬²·¹þµØÇøÖ÷ÒªÕþ¸®½ÌѧҽԺºÍ˽Á¢Ò½ÔºµÄ273Ãûִҵҽʦ£¨°üÀ¨¹ËÎÊҽʦ¡¢×¨¼ÒºÍסԺҽʦ£©½øÐÐÁ˵÷²é¡£Êý¾Ý·ÖÎöÔòÔËÓÃÁËIBM SPSS StatisticsÈí¼þ£¬°üÀ¨ÃèÊöÐÔͳ¼Æ¡¢¶ÀÁ¢Ñù±¾t¼ìÑ顢Ƥ¶ûÑ·Ïà¹ØÏµÊýÒÔ¼°µ¥ÒòËØ·½²î·ÖÎö£¨ANOVA£©µÈ·½·¨£¬ÒÔÆÀ¹ÀEBMʵ¼ùµÄ¾ö¶¨ÒòËØ¼°ÆäÔÚ²»Í¬ÈºÌå¼äµÄ²îÒì¡£
Ñо¿½á¹û
1. Ñù±¾ÈË¿ÚÑ§ÌØÕ÷
Ñо¿¹²ÄÉÈë273Ãûҽʦ¡£ÆäÖУ¬ÄÐÐÔÕ¼Ö÷µ¼£¨71.8%£©£¬´ó¶àÊý²ÎÓëÕßÄêÁäÔÚ25-35ËêÖ®¼ä£¨57.5%£©£¬ÔÚÕþ¸®Ò½Ôº¹¤×÷£¨86.4%£©£¬ÇÒÓµÓÐÉÙÓÚ10ÄêµÄ¹¤×÷¾­Ñ飨68.9%£©¡£³¬¹ýÒ»°ë£¨53.1%£©µÄҽʦӵÓÐÑо¿Éú»òר¿ÆÒ½Ê¦×ʸñ£¬±íÃ÷ÕâÊÇÒ»¸ö½ÓÊܹýÒ»¶¨¿ÆÑз½·¨ÑµÁ·µÄÔçÆÚְҵȺÌå¡£
2. ֪ʶÀ´Ô´ÓëEBM×ÊԴʹÓÃÇé¿ö
ÔÚÈÕ³£ÐÅÏ¢×ÉѯÖУ¬ÄÚ²¿Í¬ÊºͿÆÑ§Êý¾Ý¿âÊÇҽʦ×ʹÓõÄ×ÊÔ´¡£È»¶ø£¬¶ÔרҵEBMÊý¾Ý¿âµÄÊìϤ¶ÈºÍʹÓÃÆµÂʽÒʾÁËÏÔÖø²îÒì¡£PubMedÊÇ×î³£±»Æµ·±·ÃÎʵÄ×ÊÔ´£¨52.7%£©£¬Æä´ÎÊÇÁÙ´²Ö¸ÄÏ£¨52.0%£©ºÍҽѧÆÚ¿¯£¨33.7%£©¡£Ïà±È֮ϣ¬¿Æ¿ËÂ×ͼÊé¹Ý£¨Cochrane Library, 13.6%£©¡¢°®Ë¼Î¨¶û£¨Elsevier, 17.2%£©¡¢¿ÆÑ§ÒýÎÄË÷Òý£¨ISI Web of Science, 12.1%£©ºÍºÉÀ¼Ò½Ñ§ÎÄÕªÊý¾Ý¿â£¨Embase, 9.9%£©µÈרҵÊý¾Ý¿âµÄʹÓÃÂÊÔòµÍµÃ¶à¡£Ò»¸öÖµµÃ×¢ÒâµÄÏÖÏóÊÇ£¬Ðí¶àҽʦ¶ÔÐèÒª»ú¹¹¶©ÔĵÄרҵÊý¾Ý¿â±íÏÖ³ö¸ß¡°´Ó²»ÔĶÁ¡±Âʺ͡°Î´Öª¡±ÂÊ£¬°µÊ¾ÁË·ÃÎÊȨÏÞ»òÈÏÖª¶ÈµÄÏÞÖÆ¡£
3. ¶ÔEBMµÄ̬¶È
ҽʦ¶ÔEBMµÄ̬¶ÈÕûÌå·Ç³£»ý¼«¡£ËûÃÇÆÕ±éͬÒâEBMÄÜÌá¸ß»¼Õß»¤ÀíÖÊÁ¿£¨Æ½¾ùµÃ·Ö=1.15£©ºÍҽʦ¹¤×÷ÖÊÁ¿£¨Æ½¾ùµÃ·Ö=1.11£©£¬²¢ÈÏΪҽѧ½ÌÓýÏîĿӦ¸üÖØÊÓEBM£¨Æ½¾ùµÃ·Ö=0.99£©¡£¶Ô¡°EBM²»ÊÊÓÃÓÚҽʦ¡±»ò¡°EBMδÄܹ«Õý¶Ô´ýҽʦµÄ¾­ÑéºÍ֪ʶ¡±µÈ¸ºÃæ³ÂÊö£¬Ò½Ê¦ÃDZí´ïÁ˲»Í¬Ò⣨ƽ¾ùµÃ·Ö·Ö±ðΪ-0.16ºÍ-0.11£©¡£Ì¬¶ÈµÃ·ÖÓëEBMʵ¼ùˮƽ³ÊÖжÈÕýÏà¹Ø£¨r = 0.35¨C0.42, p < 0.001£©£¬±íÃ÷»ý¼«Ì¬¶ÈÓë¸ü¸ßµÄÖ¤¾ÝÓ¦ÓÃÏà¹Ø¡£
4. EBMʵ¼ùˮƽÓëÕϰ­
ҽʦ×Ô±¨µÄÿÈÕÁÙ´²Êµ¼ùÖлùÓÚEBMµÄ±ÈÀýÖÐλÊýΪ50%£¨ËÄ·Öλ¾à£º10-80%£©£¬Æ½¾ùֵΪ47.2%£¬±íÃ÷Ö¤¾ÝÔÚ³£¹æ»¤ÀíÖеÄÕûºÏ³Ì¶ÈΪÖеȡ£³¬¹ý°ëÊý£¨60.4%£©µÄҽʦ±íʾ»áÔÚÁÙ´²Ó¦ÓÃǰ¶ÔÑо¿ÎÄÕ½øÐÐÅúÅÐÐÔÆÀ¹À¡£Ñо¿Ê¶±ð³öµÄÖ÷ÒªÕϰ­°üÀ¨£ºÈÏΪ¡°Ã¿¸öÒ½ÁÆ»ú¹¹¶¼ÊǶÀÌØµÄ£¬Òò´ËÑо¿·¢ÏÖ²»ÄÜÆÕ±éÊÊÓá±£¨58.6%£©£»ÈÏΪ¡°Ò½Ê¦¶ÔÑо¿·½·¨Àí½â²»×㡱£¨57.5%£©£»ÒÔ¼°ÈÏΪ¡°Ñо¿·¢ÏÖÀíÂÛÉϺÏÀíµ«ÔÚʵ¼Ê»·¾³Öв»ÊµÓá±£¨38.5%£©¡£½öÓÐÉÙÊýҽʦÈÏͬ¡°Ò½Éú¶ÔÑо¿²»¸ÐÐËȤ¡±£¨18.3%£©»ò¡°Ñо¿ÂÛÎÄÌ«¸´ÔÓÄÑÒÔ½â¶Á¡±£¨15.0%£©¡£
5. Ò½ÔºÀàÐÍÓëרҵ×ʸñ¶ÔEBMʵ¼ùµÄÓ°Ïì
±È½ÏÕþ¸®Ò½Ôº£¨n = 236£©ºÍ˽Á¢Ò½Ôº£¨n = 37£©Ò½Ê¦µÄEBMʵ¼ùˮƽ£¬Î´·¢ÏÖͳ¼ÆÑ§ÉϵÄÏÔÖø²îÒ죨p = 0.511£©£¬±íÃ÷Õϰ­Êǿ粿Ãůձ鴿ÔÚµÄϵͳÐÔÎÊÌ⡣Ȼ¶ø£¬µ¥ÒòËØ·½²î·ÖÎö£¨ANOVA£©ÏÔʾ£¬²»Í¬×¨Òµ×ʸñ£¨±Ïҵˮƽ£©µÄҽʦÔÚEBMʵ¼ù±ÈÀýÉÏ´æÔÚÏÔÖø²îÒ죨F(9, 263) = 2.22, p = 0.0212£©¡£¾ßÌå¶øÑÔ£¬ÓµÓÐÌØ¶¨Ñ§ÊõÑо¿Ñ§Î»£¨Èç˶ʿ¡¢Ñо¿ÉúÎÄÆ¾£©µÄҽʦȺÌåÏÔʾ³ö¸ü¸ßµÄÖÐλEBM·ÖÊý£¨½Ó½ü90%£©£¬¶ø½öÓµÓÐҽѧѧʿ£¨MBBS£©»òר¿ÆÎ¯Ô±»áÈÏÖ¤µÄҽʦȺÌåµÃ·Ö½ÏµÍ£¨Ô¼40-50%£©£¬ÇÒ·Ö²¼¸üÀëÉ¢¡£
½áÂÛÓëÌÖÂÛ
±¾Ñо¿½ÒʾÁËÒ»¸öÔÚÒ½ÁÆÊµ¼ùÖг£¼ûµÄ¡°ÖªÐÅÐС±²»Æ¥ÅäÏÖÏó£ºÉ³Ìذ¬²·¹þµØÇøµÄҽʦ¶Ôѭ֤ҽѧ£¨EBM£©ÆÕ±é³ÖÓлý¼«ºÍÈϿɵÄ̬¶È£¬µ«½«Ö¤¾Ýϵͳ¡¢³£¹æµØÕûºÏµ½ÈÕ³£ÁÙ´²¾ö²ßÖеÄʵ¼Êˮƽ½öΪÖеȡ£¾¡¹ÜPubMedºÍÁÙ´²Ö¸ÄÏÊÇÏà¶Ô³£ÓõÄ×ÊÔ´£¬µ«¶Ô¿Æ¿ËÂ×ͼÊé¹Ý¡¢EmbaseµÈ¸ßÖÊÁ¿×¨ÒµÖ¤¾ÝÊý¾Ý¿âµÄÀûÓÃÈÔÈ»·Ç³£ÓÐÏÞ£¬Õâ¿ÉÄÜ»áÓ°ÏìËù»ñȡ֤¾ÝµÄÈ«ÃæÐÔºÍÖÊÁ¿¡£Ñо¿½á¹ûÇ¿µ÷£¬×è°­EBMʵʩµÄ¹Ø¼ü²¢·Çҽʦȱ·¦ÐËȤ»òÈϿɣ¬¶øÊǽṹÐÔÕϰ­ÓëÈÏÖªÌôÕ½µÄµþ¼Ó¡£×îÖ÷ÒªµÄÕϰ­°üÀ¨Ê±¼äÏÞÖÆ¡¢¶ÔÑо¿·¢ÏÖÆÕÊÊÐԵϳÒÉ£¬ÒÔ¼°¶ÔÑо¿·½·¨µÄÀí½âÓÐÏÞ¡£ÕâЩÕϰ­ÔÚÕþ¸®Ò½ÔººÍ˽Á¢Ò½ÔºÖÐͬÑù´æÔÚ£¬ËµÃ÷ÎÊÌâ¾ßÓÐϵͳÐÔ¡£
¸ÃÑо¿µÄ·¢ÏÖ¾ßÓÐÖØÒªµÄÏÖʵÒâÒå¡£ËüÖ¸³ö£¬µ¥´¿Ìá¸ßEBMÒâʶ»ò¸Ä±ä̬¶È²»×ãÒÔ´øÀ´ÁÙ´²ÐÐΪµÄ¸ù±¾×ª±ä¡£Î´À´µÄ¸ÉÔ¤´ëÊ©±ØÐëÊǶà²ãÃæµÄ£ºÔÚ¸öÌå²ãÃæ£¬ÐèҪͨ¹ý½á¹¹»¯ÅàѵÏîÄ¿ÌáÉýҽʦµÄÑо¿ËØÑø¡¢ÅúÅÐÐÔÆÀ¹ÀÄÜÁ¦ºÍ¸ß¼¶ÎÄÏ×¼ìË÷¼¼ÄÜ£»ÔÚ×éÖ¯²ãÃæ£¬Ò½ÁÆ»ú¹¹ÐèÒªÌṩÒ×ÓÚ·ÃÎʵÄÖ¤¾Ý×ÊÔ´£¨Èç¶©ÔÄרҵÊý¾Ý¿â£©¡¢ÔÚÁÙ´²¹¤×÷Á÷³ÌÖÐÕûºÏ¾ö²ßÖ§³Ö¹¤¾ß£¬²¢¿¼ÂÇΪ֤¾ÝÉó²éÌṩÊܱ£»¤µÄʱ¼ä£»ÔÚÕþ²ß²ãÃæ£¬ÎÀÉú¹ÜÀíÕߺÍÒ½ÔºÁìµ¼ÐèÒª¹«¿ª³«µ¼²¢Ö§³Öѭ֤ʵ¼ù£¬½«ÆäÄÉÈ뼨ЧÆÀ¹À¿ò¼Ü£¬´Ó¶øÓªÔìÒ»ÖÖ¹ÄÀøºÍ½±Àø»ùÓÚÖ¤¾Ý½øÐоö²ßµÄ×éÖ¯ÎÄ»¯¡£Í¨¹ýÕâÖÖÕë¶ÔÈÏÖª¡¢×éÖ¯ºÍ×ÊÔ´Ïà¹ØÕϰ­µÄ×ۺϲßÂÔ£¬²ÅÄܸüÓÐЧµØÃÖºÏ̬¶ÈÓëʵ¼ùÖ®¼äµÄºè¹µ£¬×îÖÕÌáÉýÕûÌåµÄÒ½ÁÆ·þÎñÖÊÁ¿¡£
Ïà¹ØÐÂÎÅ
ÉúÎïͨ΢ÐŹ«ÖÚºÅ
΢ÐÅ
ÐÂÀË΢²©

ÈȵãÅÅÐÐ

    ½ñÈÕ¶¯Ì¬ | È˲ÅÊг¡ | м¼ÊõרÀ¸ | Öйú¿ÆÑ§ÈË | ÔÆÕ¹Ì¨ | BioHot | ÔÆ½²ÌÃÖ±²¥ | »áÕ¹ÖÐÐÄ | ÌØ¼ÛרÀ¸ | ¼¼Êõ¿ìѶ | Ãâ·ÑÊÔÓÃ

    °æÈ¨ËùÓÐ ÉúÎïͨ

    Copyright© eBiotrade.com, All Rights Reserved

    ÁªÏµÐÅÏ䣺

    ÔÁICP±¸09063491ºÅ